Literature DB >> 18367981

Introduction and review of collection techniques and applications of drug testing of oral fluid.

Olaf H Drummer1.   

Abstract

The past several years have seen substantial developments in the use of alternative specimens for drug analysis. The use of oral fluid has been found to offer significant promise when detection of relatively recent use of drugs is sought in a relatively noninvasive manner. Although there are a number of factors that affect drug concentration in oral fluid, there appears to be a reasonable correlation between blood and oral fluid concentrations of drugs. Collection techniques can artificially affect production of oral fluid and its subsequent pH. These need to be understood, as does local absorption of drug, in situations where drug may be present in the oral cavity (eg, smoking or sublingual absorption). Nevertheless, it is essential that devices used to collect oral fluid are checked to ensure reasonable stability and recovery of absorbed drug. The most common applications include workplace testing for drugs of abuse, particularly post-incident, and roadside detection of illicit drugs. Therapeutic drug monitoring has been shown to be useful for a number of drugs that have traditionally been measured in plasma/serum.

Mesh:

Year:  2008        PMID: 18367981     DOI: 10.1097/FTD.0b013e3181679015

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  12 in total

1.  Analysis of Urine, Oral fluid and Fingerprints by Liquid Extraction Surface Analysis Coupled to High Resolution MS and MS/MS - Opportunities for Forensic and Biomedical Science.

Authors:  Melanie Bailey; Elizabeth C Randall; Catia Costa; Tara L Salter; Alan M Race; Marcel de Puit; Mattijs Koeberg; Mark Baumert; Josephine Bunch
Journal:  Anal Methods       Date:  2016-03-24       Impact factor: 2.896

2.  Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure.

Authors:  Vincent Blandino; Jillian Wetzel; Jiyoung Kim; Petrit Haxhi; Richard Curtis; Marta Concheiro
Journal:  Curr Pharm Biotechnol       Date:  2017       Impact factor: 2.837

3.  MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration.

Authors:  Allan J Barnes; Karl B Scheidweiler; Erin A Kolbrich-Spargo; David A Gorelick; Robert S Goodwin; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2011-10       Impact factor: 3.681

4.  Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration.

Authors:  Karl B Scheidweiler; Erin A Kolbrich Spargo; Tamsin L Kelly; Edward J Cone; Allan J Barnes; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2010-10       Impact factor: 3.681

Review 5.  Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.

Authors:  Mwlod Ghareeb; Fatemeh Akhlaghi
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

6.  Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration.

Authors:  Kayla N Ellefsen; Marta Concheiro; Sandrine Pirard; David A Gorelick; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2016-01-22       Impact factor: 2.395

7.  Direct drug analysis from oral fluid using medical swab touch spray mass spectrometry.

Authors:  Valentina Pirro; Alan K Jarmusch; Marco Vincenti; R Graham Cooks
Journal:  Anal Chim Acta       Date:  2015-01-07       Impact factor: 6.558

8.  Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence.

Authors:  Teresa R Gray; Riet Dams; Robin E Choo; Hendree E Jones; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2010-07-27       Impact factor: 2.395

9.  Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole.

Authors:  Kim Vanstraelen; Johan Maertens; Patrick Augustijns; Katrien Lagrou; Henriette de Loor; Raf Mols; Pieter Annaert; Anne Malfroot; Isabel Spriet
Journal:  Clin Pharmacokinet       Date:  2015-11       Impact factor: 6.447

10.  Quantification of 11-nor-9-carboxy-δ9-tetrahydrocannabinol in human oral fluid by gas chromatography-tandem mass spectrometry.

Authors:  Allan J Barnes; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2014-04       Impact factor: 3.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.